Literature DB >> 15534061

Molecular and metabolic imaging of atherosclerosis.

John R Davies1, James H Rudd, Peter L Weissberg.   

Abstract

Atherosclerosis is a systemic disease that affects most major arteries of the body and is the most common cause of premature death in the western world. It develops slowly and often asymptomatically, so that for many patients its first manifestation is sudden cardiac death, stroke, or myocardial infarction. The current gold standard for imaging atherosclerosis is x-ray angiography. However, recent advances in understanding of the pathobiology of atherosclerosis have highlighted the inadequacies of this technique and the need for better imaging approaches. The purpose of this article is to briefly outline the biology of atherosclerosis and to review the techniques available to image it, concentrating specifically on those that detect metabolic or inflammatory changes within the atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534061

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

Review 1.  Antibodies for molecular imaging in the cardiovascular system.

Authors:  Ban-An Khaw
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

2.  Inflammatory F-18 fluorodeoxyglucose uptake over arterial bypass prosthesis seen on positron emission tomography can predict acute vascular events.

Authors:  Michèle Duet; Jean Pierre Laissy; Benoit Paulmier; Patrick Rossignol; Frédéric Bernard; Nadia Ghazzar-Pierquet; Marc Faraggi
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 3.  Imaging techniques for the vulnerable coronary plaque.

Authors:  F Cademartiri; L La Grutta; A Palumbo; E Maffei; A Aldrovandi; R Malagò; F Alberghina; F Pugliese; G Runza; M Belgrano; M Midiri; M A Cova; G P Krestin
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

4.  Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.

Authors:  Simona Ben-Haim; Ela Kupzov; Ada Tamir; Alex Frenkel; Ora Israel
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 5.  Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Authors:  D Le Guludec; R Lautamäki; J Knuuti; J J Bax; F M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-26       Impact factor: 9.236

6.  Imaging of vulnerable plaques: will it affect patient management and influence outcomes?

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

7.  Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Authors:  Yuji Kuge; Nozomi Takai; Yuki Ogawa; Takashi Temma; Yan Zhao; Kantaro Nishigori; Seigo Ishino; Junko Kamihashi; Yasushi Kiyono; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

8.  Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits.

Authors:  Claudia Calcagno; Esad Vucic; Venkatesh Mani; Gregg Goldschlager; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

9.  Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.

Authors:  Yongjian Liu; Dana Abendschein; Geoffrey E Woodard; Raffaella Rossin; Kyle McCommis; Jie Zheng; Michael J Welch; Pamela K Woodard
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

Review 10.  Vascular considerations in glaucoma patients of African and European descent.

Authors:  Andrew Huck; Alon Harris; Brent Siesky; Nathaniel Kim; Michael Muchnik; Priyanka Kanakamedala; Annahita Amireskandari; Leslie Abrams-Tobe
Journal:  Acta Ophthalmol       Date:  2014-01-25       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.